Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
Recruiting
Phase 1
Phase 2
Interventional Study
Tumor
Cardiovascular Diseases
Pulmonary Fibrosis
Rheumatic Immune Diseases Involving Large Blood Vessels
Hypertrophic Cardiomyopathy (HCM)
Other Hypoxic and Fibroblast Activated Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 85
- Sex
- Any
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 30 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to conduct clinical research on \[68Ga\] Ga-NI-FAPI-04 PET/CT imaging and further investigate its diagnostic value in fibroblast activation related diseases.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 1: 18-85 years old
2: Tumor patients can undergo surgery or biopsy to obtain pathological diagnosis
3: Ability to understand and sign informed consent forms
4: Expected survival period exceeding 6 months and able to receive follow-up
5: Healthy volunteers without c…
Contacts